ArticleAnnals of medicine2025

MASS-4 is more suitable than MASS-3 for prognostic stratification in transplant-eligible patients with newly diagnosed multiple myeloma.

Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.